THE EFFECT OF TRANEXAMIC ACID ON REDUCING THE AMOUNT OF BLOOD LOSS DURING CESAREAN SECTION AT MATERNITY HOSPITAL IN DUHOK
Abstract
https://doi.org/10.31386/dmj.2022.16.2.7
Background: The Cesarean section rate is increasing worldwide. Efforts are being made to decrease Cesarean section which may lead to many complications. World Health Organization recent guidelines recommended the administration of Tranexamic acid to decrease the amount of blood loss and treat postpartum hemorrhage to reduce the risk of severe anemia and the need for blood transfusion.
Objectives: To assess the effect of Tranexamic acid on the amount of blood loss during elective cesarean section and to evaluate the reduction in the hemoglobin and hematocrit level.
Methods: This randomized control trial study was conducted during the period from 15th September 2021 to 15th January 2022, at Duhok Hospital for Obstetrics and Gynecology. The study enrolled 200 women in the age group 20 to 40 years, who were at 37 to 41+6 weeks of gestation, received regular antenatal care, had no renal, liver, heart diseases or coagulopathies and no allergy to drugs. The women were randomly allocated into two groups the interventional group G1 received 1 gm of Tranexamic acid in 100 ml normal saline for 10 minutes before starting the operation and the control group G2 did not receive it. Both groups received 10 units oxytocin IV after fetal delivery. Amount of blood loss intraoperatively, change in hemoglobin, hematocrit levels, drug side effects were observed and analyzed, and the need for extra uterotonics, blood transfusion and the occurrence of PPH among the two groups.
Results: There were no significant differences in term of age, BMI, parity, gestational age, antenatal care visits, and the indications for cesarean section between G1 and G2. There was a highly significant difference in the mean estimated blood loss (EBL) between the two Groups, which was (290±5.5 ml) for G1 and (429±81 ml) for G2, the P-value <0.001. The same for the mean Hb and hematocrit reduction with a highly significant between the two Groups, P-value <0.001. The need for extra uterotonics drugs was less in G1 compared to G2.
Conclusion: Administration of IV Tranexamic acid as a prophylaxis before starting skin incision significantly reduced the amount of blood loss intra operatively, and affected hemoglobin, hematocrit level. It deceased the need for extra uterotonics drugs.
Downloads
References
1. Aaronson, D., Harlev, A., Sheiner, E., Levy, A., 2010. Trial of labor after cesarean section in twin pregnancies: Maternal and neonatal safety. 2010. J Maternal Fetal and Neonatal Medicine, 23(6); 550-4. Doi: 10.3109/ 147605093156700.
2. Sharma, R., Najam, S., Misra, K.M. 2011. Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section. J Biomed Parmacol J, 4(1); 231-5.
3. Martin, J. A., Hamilton, B.E., Osterman, M.J.K., Driscoll, A.K. 2019. Births Final data for 2018. National Vital Statistics Reports; Center for Health Statistics (U.S), 68(13).
4. World Health Organization. 2009. WHO guidelines for the management of postpartum hemorrhage and retained placenta.
5. Goswami, U., Sarangi, S., Gupta, S., Babbar, S., 2013. Comparative evaluation of two doses of tranexamic acid used prophylactically in anemic parturients for lower segment cesarean section: A double-blind randomized case control prospective trial. Saudi Journal of Anesthesia, 7(4); 427-431. Doi: 10.4103/1658-354X.121077.
6. Pregnancy Mortality Surveillance System" U.S. 2017. Department of Health & Human Services- Centers for Disease Control and Prevention CDC, [Online]. Available: https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mortality-surveillance-system.htm. [Accessed 13 April 2022].
7. Lutomiski, J. E., Byne, B. M., Devane, D., Greene, R. A., 2011. Increasing trends in atonic postpartum hemorrhage in Ireland: an 11-year population-based cohort study. BJOG An International Journal of Obstetrics and Gynecology, 119(3); 306-14. Doi: 10.1111/j.1471-0528.2011.03198.x
8. BH, Chi., Taylor, G., 2015. Translating clinical management into an effective public health response for postpartum hemorrhage. BJOG An International Journal of Obstetrics and gynecology, 122(2); 211-211. Doi: 10.1111/1471-0528. 13221.
9. Novikova, N., Justus, H. G, Cluver, C., 2015. Tranexamic acid for preventing postpartum hemorrhage. Cochrane Library, Cochrane Database of Systemic Review, no. Issue 6. Art. No. CD007872.DOI: 10.1002/14651858.CD007872.pub3.
10. Gungorduk, K., Yıldırım, G., Asıcıoğlu, O., Gungorduk, O. C., Sudolmus, S., Cemal, Ark., 2014. Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study. American Journal of Perinatology, 28(3); 233-240. Doi: 10.1055/s-0030-1268238.
11. Senturk, M. B., Cakmak, Y., Yildiz, G., Yildiz, P., 2013. Tranexamic acid for cesarean section: a double-blind, placebo-controlled, randomized clinical trial. Maternal Fetal Medicine. Archives of Gynecology and Obstetrics J, 287; 641-5. Doi: 10.1007/s00404-012-2624-8.
12. Abdel-Aleem, H., Alhusaini, T. K., Abdel-Aleem, M. A., Menoufy, M., Gulmezoglu, A. M., 2013. Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. The Journal of Maternal Fetal and Neonatal Medicine, 26(17); 1705-1709. Doi: 10.1309/1476058.2013.794210.
13. Abd El-Naser, Abd El-Gaber., Hazem, H. A., Mustafa, M. K., Ahmed M. A., 2019. Effect of tranexamic acid in prevention of postpartum hemorrhage in elective caesarean delivery: a randomized controlled study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 8(1);1-5. Doi:10.18203/2320-1770.ijrcog20185401.
14. Albaz, Z., 2020. Role of prophylactic tranexamic acid in reducing blood loss during elective Cesarean Section. Journal of Family Medicine, 7(8); ID1227.
15. Nayyef, S. S., Maha, M. D., Ibraheem, F. A., 2020. The effect of routine intraoperative tranexamic acid in elective cesarean section. International Journal of Advanced Research in Medicine, 2(2);85-90. Doi: 10.22271/27069567.2020.v2.i2b.51.
